Bryan, Garnier & Co Analyst Recommendations & Stock Picks

Name: Community Performance Rating
Item: Bryan, Garnier & Co
Rating: 2.7
Author: MarketBeat

→ Strange new buyer driving up gold (From Stansberry Research) (Ad)

This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at Bryan, Garnier & Co. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by Bryan, Garnier & Co.

Company	Current Price	Rating Date	Action	Brokerage	Analyst	Rating	Price Target	Impact on Price	Details
MLTX MoonLake Immunotherapeutics	$42.17 -0.2%	9/14/2023	Downgraded by	Bryan, Garnier & Co	-	Buy -> Neutral		Low	View details for Bryan, Garnier & Co rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 9/14/2023
TVTX Travere Therapeutics	$5.69 -1.9%	5/5/2023	Upgraded by	Bryan, Garnier & Co	-	Sell -> Neutral		Low	View details for Bryan, Garnier & Co rating of Travere Therapeutics (NASDAQ:TVTX) on 5/5/2023
IMCR Immunocore	$55.27 +1.0%	3/24/2023	Initiated by	Bryan, Garnier & Co	-	Buy	$16.00	Low	View details for Bryan, Garnier & Co rating of Immunocore (NASDAQ:IMCR) on 3/24/2023
IMTX Immatics	$10.20 -0.6%	3/24/2023	Initiated by	Bryan, Garnier & Co	-	Buy	$16.00	Low	View details for Bryan, Garnier & Co rating of Immatics (NASDAQ:IMTX) on 3/24/2023
ADAP Adaptimmune Therapeutics	$0.97 +7.5%	3/24/2023	Initiated by	Bryan, Garnier & Co	-	Buy	$3.60	Low	View details for Bryan, Garnier & Co rating of Adaptimmune Therapeutics (NASDAQ:ADAP) on 3/24/2023
CRSP CRISPR Therapeutics	$54.92 -2.2%	3/17/2023	Initiated by	Bryan, Garnier & Co	-	Buy	$70.00	Low	View details for Bryan, Garnier & Co rating of CRISPR Therapeutics (NASDAQ:CRSP) on 3/17/2023
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
CLLS Cellectis	$2.53 +2.4%	3/17/2023	Initiated by	Bryan, Garnier & Co	-	Buy	$6.00	Low	View details for Bryan, Garnier & Co rating of Cellectis (NASDAQ:CLLS) on 3/17/2023
AUTL Autolus Therapeutics	$4.50 -6.3%	3/17/2023	Initiated by	Bryan, Garnier & Co	-	Buy	$5.00	Low	View details for Bryan, Garnier & Co rating of Autolus Therapeutics (NASDAQ:AUTL) on 3/17/2023
MLTX MoonLake Immunotherapeutics	$42.17 -0.2%	2/2/2023	Initiated by	Bryan, Garnier & Co	-	Buy	$22.00	Low	View details for Bryan, Garnier & Co rating of MoonLake Immunotherapeutics (NASDAQ:MLTX) on 2/2/2023
SAP SAP	€169.18 +0.2%	12/14/2022	Target Set by	Bryan, Garnier & Co	Analyst Gregory Ramirez		€130.00	N/A	View details for Bryan, Garnier & Co rating of SAP (ETR:SAP) on 12/14/2022
CRRFY Carrefour	$3.38 -0.3%	11/16/2022	Downgraded by	Bryan, Garnier & Co	Analyst Clement Genelot	Buy -> Neutral	$22.00 -> $20.00	Low	View details for Bryan, Garnier & Co rating of Carrefour (OTCMKTS:CRRFY) on 11/16/2022
TVTX Travere Therapeutics	$5.69 -1.9%	9/21/2022	Initiated by	Bryan, Garnier & Co	-	Sell	$17.00	Low	View details for Bryan, Garnier & Co rating of Travere Therapeutics (NASDAQ:TVTX) on 9/21/2022
TAP Molson Coors Beverage	$64.34 +0.7%	9/1/2022	Downgraded by	Bryan, Garnier & Co	Analyst Nikolaas Faes	Buy -> Sell	$54.00	Low	View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 9/1/2022
ADRNY Koninklijke Ahold Delhaize	€28.87 +0.3%	8/31/2022	Upgraded by	Bryan, Garnier & Co	Analyst Clement Genelot	Neutral -> Buy	€31.00 -> €34.00	Low	View details for Bryan, Garnier & Co rating of Koninklijke Ahold Delhaize (OTCMKTS:ADRNY) on 8/31/2022
ADYEY Adyen	$15.14 -0.4%	8/19/2022	Downgraded by	Bryan, Garnier & Co	-	Buy -> Neutral		Low	View details for Bryan, Garnier & Co rating of Adyen (OTCMKTS:ADYEY) on 8/19/2022
CMPGY Compass Group	$26.90 +0.9%	6/9/2022	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy		Medium	View details for Bryan, Garnier & Co rating of Compass Group (OTCMKTS:CMPGY) on 6/9/2022
ZLNDY Zalando	$14.28 -1.7%	6/1/2022	Downgraded by	Bryan, Garnier & Co	Analyst Clement Genelot	Neutral -> Sell	$87.00 -> $38.00	High	View details for Bryan, Garnier & Co rating of Zalando (OTCMKTS:ZLNDY) on 6/1/2022
GMAB Genmab A/S	$28.64 +1.1%	5/13/2022	Upgraded by	Bryan, Garnier & Co	Analyst Victor Floch	Sell -> Neutral		Medium	View details for Bryan, Garnier & Co rating of Genmab A/S (NASDAQ:GMAB) on 5/13/2022
NVO Novo Nordisk A/S	$122.77 +0.0%	5/5/2022	Upgraded by	Bryan, Garnier & Co	-	Sell -> Neutral		Low	View details for Bryan, Garnier & Co rating of Novo Nordisk A/S (NYSE:NVO) on 5/5/2022
BLDR Builders FirstSource	$176.18 -3.3%	4/6/2022	Downgraded by	Bryan, Garnier & Co	-	Buy -> Neutral	$71.00	High	View details for Bryan, Garnier & Co rating of Builders FirstSource (NYSE:BLDR) on 4/6/2022
HNNMY H & M Hennes & Mauritz AB (publ)	$3.04	4/4/2022	Downgraded by	Bryan, Garnier & Co	Analyst Cedric Rossi	Buy -> Neutral	$225.00 -> $190.00	Low	View details for Bryan, Garnier & Co rating of H & M Hennes & Mauritz AB (publ) (OTCMKTS:HNNMY) on 4/4/2022
MTLS Materialise	$5.08 +1.2%	3/25/2022	Downgraded by	Bryan, Garnier & Co	Analyst Gregory Ramirez	Buy -> Neutral	$20.00	Low	View details for Bryan, Garnier & Co rating of Materialise (NASDAQ:MTLS) on 3/25/2022
DASTY Dassault Systèmes	$40.62 -0.1%	3/25/2022	Downgraded by	Bryan, Garnier & Co	Analyst Gregory Ramirez	Buy -> Neutral	$49.00	High	View details for Bryan, Garnier & Co rating of Dassault Systèmes (OTCMKTS:DASTY) on 3/25/2022
TIIAY Telecom Italia	$2.29 -2.6%	3/14/2022	Upgraded by	Bryan, Garnier & Co	Analyst Thomas Coudry	Neutral -> Buy		Medium	View details for Bryan, Garnier & Co rating of Telecom Italia (OTCMKTS:TIIAY) on 3/14/2022
ZLNDY Zalando	$14.28 -1.7%	3/4/2022	Downgraded by	Bryan, Garnier & Co	-	Neutral		High	View details for Bryan, Garnier & Co rating of Zalando (OTCMKTS:ZLNDY) on 3/4/2022
GLPG Galapagos	$29.05 +0.5%	1/28/2022	Upgraded by	Bryan, Garnier & Co	-	Sell -> Buy		High	View details for Bryan, Garnier & Co rating of Galapagos (NASDAQ:GLPG) on 1/28/2022
NVS Novartis	$94.39 +2.0%	12/3/2021	Reiterated by	Bryan, Garnier & Co	Analyst Jeanjacques Le	Buy -> Neutral	$115.00 -> $85.00	Low	View details for Bryan, Garnier & Co rating of Novartis (NYSE:NVS) on 12/3/2021
AZN AstraZeneca	$68.60 +0.4%	11/22/2021	Downgraded by	Bryan, Garnier & Co	-	Buy		Low	View details for Bryan, Garnier & Co rating of AstraZeneca (NASDAQ:AZN) on 11/22/2021
NVO Novo Nordisk A/S	$122.77 +0.0%	11/3/2021	Downgraded by	Bryan, Garnier & Co	Analyst Jean-Jacques Le	Buy -> Sell	$148.00	High	View details for Bryan, Garnier & Co rating of Novo Nordisk A/S (NYSE:NVO) on 11/3/2021
ESLOY EssilorLuxottica Société anonyme	$108.85 +1.7%	10/29/2021	Upgraded by	Bryan, Garnier & Co	Analyst Cedric Rossi	Neutral -> Buy		High	View details for Bryan, Garnier & Co rating of EssilorLuxottica Société anonyme (OTCMKTS:ESLOY) on 10/29/2021
MTTRY Ceconomy	$0.40	10/12/2021	Downgraded by	Bryan, Garnier & Co	Analyst Clement Genelot	Buy -> Neutral		Low	View details for Bryan, Garnier & Co rating of Ceconomy (OTCMKTS:MTTRY) on 10/12/2021
BNTX BioNTech	$86.96 +0.9%	10/5/2021	Target Set by	Bryan, Garnier & Co	Analyst Olga Smolentseva		$359.00	Low	View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 10/5/2021
BNTX BioNTech	$86.96 +0.9%	9/24/2021	Target Set by	Bryan, Garnier & Co	Analyst Olga Smolentseva		$451.00	High	View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 9/24/2021
VALN Valneva	$7.93 -2.5%	9/13/2021	Downgraded by	Bryan, Garnier & Co	Analyst Jean-Jacques Le Fur	Buy -> Neutral		High	View details for Bryan, Garnier & Co rating of Valneva (NASDAQ:VALN) on 9/13/2021
ERFSF Eurofins Scientific	$63.04	8/25/2021	Downgraded by	Bryan, Garnier & Co	Analyst Bruno De	Strong-Buy -> Neutral		Low	View details for Bryan, Garnier & Co rating of Eurofins Scientific (OTCMKTS:ERFSF) on 8/25/2021
BNTX BioNTech	$86.96 +0.9%	8/11/2021	Upgraded by	Bryan, Garnier & Co	Analyst Olga Smolentseva	Neutral -> Buy		High	View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 8/11/2021
BOUYF Bouygues	$40.00	7/27/2021	Upgraded by	Bryan, Garnier & Co	Analyst Thomas Coudry	Neutral -> Buy	$37.20	Low	View details for Bryan, Garnier & Co rating of Bouygues (OTCMKTS:BOUYF) on 7/27/2021
AEXAY Atos	$0.40	7/13/2021	Downgraded by	Bryan, Garnier & Co	Analyst Gregory Ramirez	Buy -> Sell		Medium	View details for Bryan, Garnier & Co rating of Atos (OTCMKTS:AEXAY) on 7/13/2021
ERFSF Eurofins Scientific	$63.04	7/9/2021	Downgraded by	Bryan, Garnier & Co	Analyst Bruno De	Buy -> Neutral		High	View details for Bryan, Garnier & Co rating of Eurofins Scientific (OTCMKTS:ERFSF) on 7/9/2021
MOR MorphoSys	$17.92 -0.7%	6/3/2021	Downgraded by	Bryan, Garnier & Co	-	Buy -> Neutral		Medium	View details for Bryan, Garnier & Co rating of MorphoSys (NASDAQ:MOR) on 6/3/2021
Strange new buyer driving up gold (Ad) One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented." But there's a much better move you can make to get in front of these big moves today.
BNTX BioNTech	$86.96 +0.9%	5/17/2021	Reiterated by	Bryan, Garnier & Co	-	Buy -> Neutral	$135.00 -> $206.00	N/A	View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 5/17/2021
BNTX BioNTech	$86.96 +0.9%	5/11/2021	Downgraded by	Bryan, Garnier & Co	-	Buy -> Neutral	$135.00 -> $206.00	Low	View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 5/11/2021
BUD Anheuser-Busch InBev SA/NV	$58.84 +1.6%	5/6/2021	Upgraded by	Bryan, Garnier & Co	-	Sell -> Buy		Medium	View details for Bryan, Garnier & Co rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 5/6/2021
DBVT DBV Technologies	$0.67 +1.4%	5/3/2021	Upgraded by	Bryan, Garnier & Co	-	Sell -> Buy		Low	View details for Bryan, Garnier & Co rating of DBV Technologies (NASDAQ:DBVT) on 5/3/2021
AEXAY Atos	$0.40	4/6/2021	Downgraded by	Bryan, Garnier & Co	-	Buy		Low	View details for Bryan, Garnier & Co rating of Atos (OTCMKTS:AEXAY) on 4/6/2021
MTLS Materialise	$5.08 +1.2%	3/10/2021	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy	$43.00	High	View details for Bryan, Garnier & Co rating of Materialise (NASDAQ:MTLS) on 3/10/2021
ECIFY Electricité de France	$2.55	2/24/2021	Downgraded by	Bryan, Garnier & Co	-	Neutral -> Sell		Low	View details for Bryan, Garnier & Co rating of Electricité de France (OTCMKTS:ECIFY) on 2/24/2021
GNFT Genfit	$3.40 -5.3%	2/12/2021	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy		Low	View details for Bryan, Garnier & Co rating of Genfit (NASDAQ:GNFT) on 2/12/2021
IPHYF Innate Pharma	$2.65	2/9/2021	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy		Low	View details for Bryan, Garnier & Co rating of Innate Pharma (OTCMKTS:IPHYF) on 2/9/2021
DASTY Dassault Systèmes	$40.62 -0.1%	2/5/2021	Upgraded by	Bryan, Garnier & Co	-	Sell -> Buy		Low	View details for Bryan, Garnier & Co rating of Dassault Systèmes (OTCMKTS:DASTY) on 2/5/2021
VCISY Vinci	$30.11 +0.6%	1/14/2021	Upgraded by	Bryan, Garnier & Co	-	Sell -> Neutral		Medium	View details for Bryan, Garnier & Co rating of Vinci (OTCMKTS:VCISY) on 1/14/2021
IFNNY Infineon Technologies	$32.57 -2.9%	1/14/2021	Downgraded by	Bryan, Garnier & Co	-	Buy -> Neutral		Low	View details for Bryan, Garnier & Co rating of Infineon Technologies (OTCMKTS:IFNNY) on 1/14/2021
STM STMicroelectronics	$38.48 -2.9%	1/8/2021	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy		High	View details for Bryan, Garnier & Co rating of STMicroelectronics (NYSE:STM) on 1/8/2021
GLPG Galapagos	$29.05 +0.5%	12/17/2020	Downgraded by	Bryan, Garnier & Co	-	Buy -> Sell		High	View details for Bryan, Garnier & Co rating of Galapagos (NASDAQ:GLPG) on 12/17/2020
SCRYY Scor	$3.10 +2.0%	12/17/2020	Downgraded by	Bryan, Garnier & Co	-	Buy		Low	View details for Bryan, Garnier & Co rating of Scor (OTCMKTS:SCRYY) on 12/17/2020
ITMPF ITM Power	$0.63 -1.6%	12/11/2020	Initiated by	Bryan, Garnier & Co	-	Buy		Low	View details for Bryan, Garnier & Co rating of ITM Power (OTCMKTS:ITMPF) on 12/11/2020
STM STMicroelectronics	$38.48 -2.9%	12/10/2020	Downgraded by	Bryan, Garnier & Co	-	Buy -> Neutral		Low	View details for Bryan, Garnier & Co rating of STMicroelectronics (NYSE:STM) on 12/10/2020
GMAB Genmab A/S	$28.64 +1.1%	9/23/2020	Downgraded by	Bryan, Garnier & Co	-	Neutral -> Sell		High	View details for Bryan, Garnier & Co rating of Genmab A/S (NASDAQ:GMAB) on 9/23/2020
IHG InterContinental Hotels Group	$97.31 -0.7%	9/21/2020	Downgraded by	Bryan, Garnier & Co	-	Neutral -> Sell		Low	View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (NYSE:IHG) on 9/21/2020
IPHA Innate Pharma	$2.50 +6.4%	9/9/2020	Downgraded by	Bryan, Garnier & Co	-	Buy -> Neutral		Low	View details for Bryan, Garnier & Co rating of Innate Pharma (NASDAQ:IPHA) on 9/9/2020
DBVT DBV Technologies	$0.67 +1.4%	8/4/2020	Downgraded by	Bryan, Garnier & Co	-	Neutral -> Sell		High	View details for Bryan, Garnier & Co rating of DBV Technologies (NASDAQ:DBVT) on 8/4/2020
BUD Anheuser-Busch InBev SA/NV	$58.84 +1.6%	7/15/2020	Downgraded by	Bryan, Garnier & Co	-	Buy -> Sell		Low	View details for Bryan, Garnier & Co rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 7/15/2020
TAP Molson Coors Beverage	$64.34 +0.7%	7/15/2020	Upgraded by	Bryan, Garnier & Co	-	Sell -> Buy	$49.00	Low	View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 7/15/2020
DEO Diageo	$140.76 0.0%	7/8/2020	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy		Low	View details for Bryan, Garnier & Co rating of Diageo (NYSE:DEO) on 7/8/2020
BNTX BioNTech	$86.96 +0.9%	7/2/2020	Target Raised by	Bryan, Garnier & Co	-		$50.00 -> $62.00	High	View details for Bryan, Garnier & Co rating of BioNTech (NASDAQ:BNTX) on 7/2/2020
STM STMicroelectronics	$38.48 -2.9%	6/29/2020	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy		Low	View details for Bryan, Garnier & Co rating of STMicroelectronics (NYSE:STM) on 6/29/2020
GMAB Genmab A/S	$28.64 +1.1%	6/3/2020	Downgraded by	Bryan, Garnier & Co	-	Buy -> Neutral		Low	View details for Bryan, Garnier & Co rating of Genmab A/S (NASDAQ:GMAB) on 6/3/2020
AZN AstraZeneca	£108.22 -0.8%	6/2/2020	Target Raised by	Bryan, Garnier & Co	-	Buy	GBX 8,780 -> GBX 9,100	N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 6/2/2020
CGC Canopy Growth	$8.05 +2.8%	6/1/2020	Downgraded by	Bryan, Garnier & Co	-	Neutral -> Sell		High	View details for Bryan, Garnier & Co rating of Canopy Growth (NASDAQ:CGC) on 6/1/2020
GNFT Genfit	$3.40 -5.3%	5/13/2020	Downgraded by	Bryan, Garnier & Co	-	Buy -> Neutral		Medium	View details for Bryan, Garnier & Co rating of Genfit (NASDAQ:GNFT) on 5/13/2020
AZN AstraZeneca	£108.22 -0.8%	5/11/2020	Target Raised by	Bryan, Garnier & Co	-	Buy	GBX 8,550 -> GBX 8,780	N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 5/11/2020
DBVT DBV Technologies	$0.67 +1.4%	3/18/2020	Downgraded by	Bryan, Garnier & Co	-	Buy -> Neutral		High	View details for Bryan, Garnier & Co rating of DBV Technologies (NASDAQ:DBVT) on 3/18/2020
SGE The Sage Group	GBX 1,140.50 -0.4%	3/2/2020	Target Lowered by	Bryan, Garnier & Co	-	Neutral	GBX 690 -> GBX 680	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 3/2/2020
BUD Anheuser-Busch InBev SA/NV	$58.84 +1.6%	2/28/2020	Downgraded by	Bryan, Garnier & Co	-	Buy -> Neutral		High	View details for Bryan, Garnier & Co rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 2/28/2020
ACB Aurora Cannabis	$6.49 -0.8%	2/27/2020	Downgraded by	Bryan, Garnier & Co	-	Neutral -> Sell		Low	View details for Bryan, Garnier & Co rating of Aurora Cannabis (NASDAQ:ACB) on 2/27/2020
GSK GSK	GBX 1,598.94 +1.0%	2/6/2020	Target Lowered by	Bryan, Garnier & Co	-	Neutral	GBX 1,800 -> GBX 1,773	N/A	View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 2/6/2020
SAP SAP	€169.18 +0.2%	1/28/2020	Target Set by	Bryan, Garnier & Co	-	Buy	€153.00	N/A	View details for Bryan, Garnier & Co rating of SAP (ETR:SAP) on 1/28/2020
ASML ASML	$859.44 -3.3%	1/14/2020	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy		Medium	View details for Bryan, Garnier & Co rating of ASML (NASDAQ:ASML) on 1/14/2020
BRBY Burberry Group	GBX 1,131.96 +0.9%	1/10/2020	Target Raised by	Bryan, Garnier & Co	-	Neutral	GBX 1,780 -> GBX 1,860	N/A	View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 1/10/2020
AZN AstraZeneca	£108.22 -0.8%	12/19/2019	Reiterated by	Bryan, Garnier & Co	-	Buy		N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 12/19/2019
GSK GSK	GBX 1,598.94 +1.0%	12/19/2019	Target Raised by	Bryan, Garnier & Co	-	Neutral	GBX 1,660 -> GBX 1,747	N/A	View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 12/19/2019
AZN AstraZeneca	£108.22 -0.8%	11/25/2019	Upgraded by	Bryan, Garnier & Co	-	Buy	GBX 7,700 -> GBX 7,950	N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 11/25/2019
CABGY Carlsberg A/S	$25.78 +1.0%	8/12/2019	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy		Low	View details for Bryan, Garnier & Co rating of Carlsberg A/S (OTCMKTS:CABGY) on 8/12/2019
TAP Molson Coors Beverage	$64.34 +0.7%	8/1/2019	Reiterated by	Bryan, Garnier & Co	-	Neutral -> Sell	$51.00	High	View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 8/1/2019
CGC Canopy Growth	$8.05 +2.8%	7/5/2019	Downgraded by	Bryan, Garnier & Co	-	Buy -> Neutral		Low	View details for Bryan, Garnier & Co rating of Canopy Growth (NASDAQ:CGC) on 7/5/2019
WEED Canopy Growth	C$11.02 +2.1%	7/4/2019	Downgraded by	Bryan, Garnier & Co	-	Buy -> Neutral	C$85.00 -> C$60.00	N/A	View details for Bryan, Garnier & Co rating of Canopy Growth (TSE:WEED) on 7/4/2019
AZN AstraZeneca	£108.22 -0.8%	7/3/2019	Reiterated by	Bryan, Garnier & Co	-	Neutral		N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 7/3/2019
SCH SafeCharge International Group	GBX 451 +90,100.0%	5/24/2019	Reiterated by	Bryan, Garnier & Co	-	Buy		N/A	View details for Bryan, Garnier & Co rating of SafeCharge International Group (LON:SCH) on 5/24/2019
BURBY Burberry Group	$14.24 -2.4%	5/20/2019	Upgraded by	Bryan, Garnier & Co	-	Sell -> Neutral		Low	View details for Bryan, Garnier & Co rating of Burberry Group (OTCMKTS:BURBY) on 5/20/2019
BRBY Burberry Group	GBX 1,131.96 +0.9%	5/20/2019	Upgraded by	Bryan, Garnier & Co	-	Neutral		N/A	View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 5/20/2019
Strange new buyer driving up gold (Ad) One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented." But there's a much better move you can make to get in front of these big moves today.
GSK GSK	GBX 1,598.94 +1.0%	5/2/2019	Target Lowered by	Bryan, Garnier & Co	-	Neutral	GBX 1,710 -> GBX 1,660	N/A	View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 5/2/2019
PDRDY Pernod Ricard	$47.12	3/29/2019	Downgraded by	Bryan, Garnier & Co	-	Buy -> Neutral		Low	View details for Bryan, Garnier & Co rating of Pernod Ricard (OTCMKTS:PDRDY) on 3/29/2019
AZN AstraZeneca	£108.22 -0.8%	3/29/2019	Reiterated by	Bryan, Garnier & Co	-	Neutral		N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 3/29/2019
AZN AstraZeneca	£108.22 -0.8%	2/22/2019	Downgraded by	Bryan, Garnier & Co	-	Neutral		N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 2/22/2019
IHG InterContinental Hotels Group	GBX 7,816 -0.3%	2/19/2019	Reiterated by	Bryan, Garnier & Co	-	Sell		N/A	View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 2/19/2019
SGE The Sage Group	GBX 1,140.50 -0.4%	1/17/2019	Target Lowered by	Bryan, Garnier & Co	-	Buy	GBX 850 -> GBX 630	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 1/17/2019
AZN AstraZeneca	£108.22 -0.8%	11/8/2018	Downgraded by	Bryan, Garnier & Co	-	Neutral		N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 11/8/2018
SCH SafeCharge International Group	GBX 451 +90,100.0%	9/13/2018	Target Raised by	Bryan, Garnier & Co	-	Buy	GBX 354 -> GBX 380	N/A	View details for Bryan, Garnier & Co rating of SafeCharge International Group (LON:SCH) on 9/13/2018
LVMUY LVMH Moët Hennessy - Louis Vuitton, Société Européenne	$170.18 -0.3%	4/24/2018	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy		Medium	View details for Bryan, Garnier & Co rating of LVMH Moët Hennessy - Louis Vuitton, Société Européenne (OTCMKTS:LVMUY) on 4/24/2018
SOW Software Aktiengesellschaft	€36.68	4/17/2018	Target Set by	Bryan, Garnier & Co	-	Buy	€49.00	N/A	View details for Bryan, Garnier & Co rating of Software Aktiengesellschaft (ETR:SOW) on 4/17/2018
MOR MorphoSys	€67.70	4/9/2018	Target Set by	Bryan, Garnier & Co	-	Buy	€91.00	N/A	View details for Bryan, Garnier & Co rating of MorphoSys (ETR:MOR) on 4/9/2018
SAP SAP	€169.18 +0.2%	4/6/2018	Target Set by	Bryan, Garnier & Co	-	Buy	€112.00	N/A	View details for Bryan, Garnier & Co rating of SAP (ETR:SAP) on 4/6/2018
MOR MorphoSys	€67.70	3/14/2018	Target Set by	Bryan, Garnier & Co	-	Buy	€91.20	N/A	View details for Bryan, Garnier & Co rating of MorphoSys (ETR:MOR) on 3/14/2018
IGY innogy SE (IGY.F)	€43.60	3/12/2018	Target Set by	Bryan, Garnier & Co	-	Neutral	€31.00	N/A	View details for Bryan, Garnier & Co rating of innogy SE (IGY.F) (ETR:IGY) on 3/12/2018
IHG InterContinental Hotels Group	GBX 7,816 -0.3%	2/20/2018	Reiterated by	Bryan, Garnier & Co	-	Sell	GBX 4,100	N/A	View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 2/20/2018
ONC Oncimmune	GBX 28 -3.8%	2/13/2018	Target Raised by	Bryan, Garnier & Co	-	Buy	GBX 154 -> GBX 168	N/A	View details for Bryan, Garnier & Co rating of Oncimmune (LON:ONC) on 2/13/2018
DGE Diageo	GBX 2,836.50 +0.5%	1/25/2018	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 2,320	N/A	View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 1/25/2018
SGE The Sage Group	GBX 1,140.50 -0.4%	1/25/2018	Target Lowered by	Bryan, Garnier & Co	-	Buy	GBX 860 -> GBX 850	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 1/25/2018
AZN AstraZeneca	£108.22 -0.8%	12/15/2017	Reiterated by	Bryan, Garnier & Co	-	Buy		N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 12/15/2017
SGE The Sage Group	GBX 1,140.50 -0.4%	11/23/2017	Target Raised by	Bryan, Garnier & Co	-	Buy	GBX 830 -> GBX 860	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 11/23/2017
BRBY Burberry Group	GBX 1,131.96 +0.9%	11/10/2017	Reiterated by	Bryan, Garnier & Co	-	Sell		N/A	View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 11/10/2017
ULVR Unilever	GBX 3,811 +1.1%	10/20/2017	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 4,350	N/A	View details for Bryan, Garnier & Co rating of Unilever (LON:ULVR) on 10/20/2017
SGPYY The Sage Group	$57.82 -0.9%	9/24/2017	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy		N/A	View details for Bryan, Garnier & Co rating of The Sage Group (OTCMKTS:SGPYY) on 9/24/2017
SGPYY The Sage Group	$57.82 -0.9%	9/22/2017	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy		Low	View details for Bryan, Garnier & Co rating of The Sage Group (OTCMKTS:SGPYY) on 9/22/2017
SGE The Sage Group	GBX 1,140.50 -0.4%	9/22/2017	Upgraded by	Bryan, Garnier & Co	-	Buy	GBX 720 -> GBX 830	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 9/22/2017
GSK GSK	GBX 1,598.94 +1.0%	9/19/2017	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 1,710	N/A	View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 9/19/2017
TSCO Tesco	GBX 281.40 -0.5%	9/12/2017	Reiterated by	Bryan, Garnier & Co	-	Sell	GBX 170	N/A	View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 9/12/2017
AZN AstraZeneca	£108.22 -0.8%	9/11/2017	Upgraded by	Bryan, Garnier & Co	-	Buy	GBX 4,700 -> GBX 5,380	N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 9/11/2017
BRBY Burberry Group	GBX 1,131.96 +0.9%	9/11/2017	Reiterated by	Bryan, Garnier & Co	-	Sell		N/A	View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 9/11/2017
888 888	GBX 82.17 +3.0%	9/5/2017	Reiterated by	Bryan, Garnier & Co	-	Buy	GBX 330	N/A	View details for Bryan, Garnier & Co rating of 888 (LON:888) on 9/5/2017
CPG Compass Group	GBX 2,203 +1.6%	8/29/2017	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 1,550	N/A	View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 8/29/2017
ULVR Unilever	GBX 3,811 +1.1%	8/25/2017	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 4,300	N/A	View details for Bryan, Garnier & Co rating of Unilever (LON:ULVR) on 8/25/2017
IHG InterContinental Hotels Group	GBX 7,816 -0.3%	8/24/2017	Reiterated by	Bryan, Garnier & Co	-	Sell	GBX 3,520	N/A	View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 8/24/2017
DGE Diageo	GBX 2,836.50 +0.5%	8/23/2017	Target Raised by	Bryan, Garnier & Co	-	Neutral	GBX 2,210 -> GBX 2,320	N/A	View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 8/23/2017
GSK GSK	GBX 1,598.94 +1.0%	7/26/2017	Target Raised by	Bryan, Garnier & Co	-	Buy	GBX 1,750 -> GBX 1,790	N/A	View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 7/26/2017
GSK GSK	GBX 1,598.94 +1.0%	7/20/2017	Reiterated by	Bryan, Garnier & Co	-	Buy	GBX 1,750	N/A	View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 7/20/2017
TSCO Tesco	GBX 281.40 -0.5%	6/20/2017	Reiterated by	Bryan, Garnier & Co	-	Sell	GBX 170	N/A	View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 6/20/2017
TSCO Tesco	GBX 281.40 -0.5%	6/14/2017	Reiterated by	Bryan, Garnier & Co	-	Sell	GBX 170	N/A	View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 6/14/2017
GSK GSK	GBX 1,598.94 +1.0%	5/31/2017	Reiterated by	Bryan, Garnier & Co	-	Buy	GBX 1,750	N/A	View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 5/31/2017
BRBY Burberry Group	GBX 1,131.96 +0.9%	4/20/2017	Reiterated by	Bryan, Garnier & Co	-	Sell		N/A	View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 4/20/2017
BRBY Burberry Group	GBX 1,131.96 +0.9%	4/13/2017	Reiterated by	Bryan, Garnier & Co	-	Sell	GBX 1,350	N/A	View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 4/13/2017
TSCO Tesco	GBX 281.40 -0.5%	4/13/2017	Reiterated by	Bryan, Garnier & Co	-	Sell	GBX 170	N/A	View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 4/13/2017
TSCO Tesco	GBX 281.40 -0.5%	3/23/2017	Reiterated by	Bryan, Garnier & Co	-	Sell	GBX 170	N/A	View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 3/23/2017
DGE Diageo	GBX 2,836.50 +0.5%	3/17/2017	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 2,210	N/A	View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 3/17/2017
SGE The Sage Group	GBX 1,140.50 -0.4%	3/6/2017	Target Raised by	Bryan, Garnier & Co	-	Neutral	GBX 640 -> GBX 660	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 3/6/2017
AZN AstraZeneca	£108.22 -0.8%	2/28/2017	Reiterated by	Bryan, Garnier & Co	-	Buy	GBX 5,400	N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 2/28/2017
IHG InterContinental Hotels Group	GBX 7,816 -0.3%	2/21/2017	Reiterated by	Bryan, Garnier & Co	-	Sell	GBX 2,950	N/A	View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 2/21/2017
CPG Compass Group	GBX 2,203 +1.6%	2/3/2017	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 1,475	N/A	View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 2/3/2017
SGE The Sage Group	GBX 1,140.50 -0.4%	2/1/2017	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 640	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 2/1/2017
TSCO Tesco	GBX 281.40 -0.5%	1/30/2017	Reiterated by	Bryan, Garnier & Co	-	Sell	GBX 170	N/A	View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 1/30/2017
Strange new buyer driving up gold (Ad) One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented." But there's a much better move you can make to get in front of these big moves today.
ULVR Unilever	GBX 3,811 +1.1%	1/27/2017	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 3,570	N/A	View details for Bryan, Garnier & Co rating of Unilever (LON:ULVR) on 1/27/2017
DGE Diageo	GBX 2,836.50 +0.5%	1/26/2017	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 2,150	N/A	View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 1/26/2017
SGE The Sage Group	GBX 1,140.50 -0.4%	1/26/2017	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 650	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 1/26/2017
BRBY Burberry Group	GBX 1,131.96 +0.9%	1/18/2017	Reiterated by	Bryan, Garnier & Co	-	Sell	GBX 1,350	N/A	View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 1/18/2017
DGE Diageo	GBX 2,836.50 +0.5%	1/16/2017	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 2,150	N/A	View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 1/16/2017
MRK Merck & Co., Inc.	$125.98 +0.6%	1/13/2017	Initiated by	Bryan, Garnier & Co	-	Buy		N/A	View details for Bryan, Garnier & Co rating of Merck & Co., Inc. (NYSE:MRK) on 1/13/2017
BRBY Burberry Group	GBX 1,131.96 +0.9%	1/10/2017	Reiterated by	Bryan, Garnier & Co	-	Sell	GBX 1,350	N/A	View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 1/10/2017
CPG Compass Group	GBX 2,203 +1.6%	1/9/2017	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 1,430	N/A	View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 1/9/2017
AZN AstraZeneca	£108.22 -0.8%	1/9/2017	Reiterated by	Bryan, Garnier & Co	-	Buy	GBX 5,250	N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 1/9/2017
GSK GSK	GBX 1,598.94 +1.0%	1/9/2017	Reiterated by	Bryan, Garnier & Co	-	Buy	GBX 1,850	N/A	View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 1/9/2017
PNN Pennon Group	GBX 661 +1.9%	1/6/2017	Reiterated by	Bryan, Garnier & Co	-	Sell	GBX 830	N/A	View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 1/6/2017
BRBY Burberry Group	GBX 1,131.96 +0.9%	1/4/2017	Downgraded by	Bryan, Garnier & Co	-	Sell	GBX 1,350	N/A	View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 1/4/2017
DGE Diageo	GBX 2,836.50 +0.5%	1/4/2017	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 2,150	N/A	View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 1/4/2017
ULVR Unilever	GBX 3,811 +1.1%	1/4/2017	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 3,990	N/A	View details for Bryan, Garnier & Co rating of Unilever (LON:ULVR) on 1/4/2017
TSCO Tesco	GBX 281.40 -0.5%	1/4/2017	Reiterated by	Bryan, Garnier & Co	-	Sell	GBX 170	N/A	View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 1/4/2017
AZN AstraZeneca	£108.22 -0.8%	12/12/2016	Reiterated by	Bryan, Garnier & Co	-	Buy	GBX 5,100	N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 12/12/2016
SGE The Sage Group	GBX 1,140.50 -0.4%	11/30/2016	Reiterated by	Bryan, Garnier & Co	-	Sell	GBX 690	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 11/30/2016
CMPGY Compass Group	$26.90 +0.9%	11/25/2016	Reiterated by	Bryan, Garnier & Co	-	Neutral		N/A	View details for Bryan, Garnier & Co rating of Compass Group (OTCMKTS:CMPGY) on 11/25/2016
DGE Diageo	GBX 2,836.50 +0.5%	11/23/2016	Reiterated by	Bryan, Garnier & Co	-	Neutral		N/A	View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 11/23/2016
AZN AstraZeneca	£108.22 -0.8%	11/22/2016	Reiterated by	Bryan, Garnier & Co	-	Buy	GBX 5,100	N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 11/22/2016
CPG Compass Group	GBX 2,203 +1.6%	11/22/2016	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 1,450	N/A	View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 11/22/2016
AZN AstraZeneca	£108.22 -0.8%	10/26/2016	Reiterated by	Bryan, Garnier & Co	-	Buy	GBX 5,220	N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 10/26/2016
BRBY Burberry Group	GBX 1,131.96 +0.9%	10/25/2016	Target Raised by	Bryan, Garnier & Co	-	Neutral	GBX 1,260 -> GBX 1,350	N/A	View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 10/25/2016
BRBY Burberry Group	GBX 1,131.96 +0.9%	10/19/2016	Target Raised by	Bryan, Garnier & Co	-	Neutral	GBX 1,200 -> GBX 1,250	N/A	View details for Bryan, Garnier & Co rating of Burberry Group (LON:BRBY) on 10/19/2016
AZN AstraZeneca	£108.22 -0.8%	10/17/2016	Reiterated by	Bryan, Garnier & Co	-	Buy	GBX 5,220	N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 10/17/2016
GSK GSK	GBX 1,598.94 +1.0%	10/17/2016	Reiterated by	Bryan, Garnier & Co	-	Buy		N/A	View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 10/17/2016
SGE The Sage Group	GBX 1,140.50 -0.4%	10/12/2016	Target Raised by	Bryan, Garnier & Co	-	Sell	GBX 600 -> GBX 690	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 10/12/2016
TSCO Tesco	GBX 281.40 -0.5%	10/5/2016	Reiterated by	Bryan, Garnier & Co	-	Sell	GBX 166	N/A	View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 10/5/2016
AZN AstraZeneca	£108.22 -0.8%	10/4/2016	Target Lowered by	Bryan, Garnier & Co	-	Buy	GBX 5,400 -> GBX 5,220	N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 10/4/2016
SGE The Sage Group	GBX 1,140.50 -0.4%	9/30/2016	Reiterated by	Bryan, Garnier & Co	-	Sell	GBX 600	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 9/30/2016
IHG InterContinental Hotels Group	GBX 7,816 -0.3%	9/27/2016	Downgraded by	Bryan, Garnier & Co	-	Sell	GBX 2,650 -> GBX 2,950	N/A	View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 9/27/2016
AZN AstraZeneca	£108.22 -0.8%	7/28/2016	Reiterated by	Bryan, Garnier & Co	-	Buy		N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 7/28/2016
GSK GSK	GBX 1,598.94 +1.0%	7/28/2016	Reiterated by	Bryan, Garnier & Co	-	Buy		N/A	View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 7/28/2016
TAP Molson Coors Beverage	$64.34 +0.7%	7/8/2016	Upgraded by	Bryan, Garnier & Co	-	Buy		N/A	View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 7/8/2016
SGE The Sage Group	GBX 1,140.50 -0.4%	5/5/2016	Reiterated by	Bryan, Garnier & Co	-	Sell	GBX 550	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 5/5/2016
TSCO Tesco	GBX 281.40 -0.5%	4/4/2016	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 166	N/A	View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 4/4/2016
CPG Compass Group	GBX 2,203 +1.6%	4/4/2016	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 1,200	N/A	View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 4/4/2016
AZN AstraZeneca	£108.22 -0.8%	3/10/2016	Reiterated by	Bryan, Garnier & Co	-	Buy	GBX 5,520	N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 3/10/2016
PNN Pennon Group	GBX 661 +1.9%	2/11/2016	Downgraded by	Bryan, Garnier & Co	-	Sell	GBX 825	N/A	View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 2/11/2016
PNN Pennon Group	GBX 661 +1.9%	2/4/2016	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 800	N/A	View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 2/4/2016
SGE The Sage Group	GBX 1,140.50 -0.4%	1/28/2016	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 570	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 1/28/2016
GSK GSK	$39.71 +1.1%	1/27/2016	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy		N/A	View details for Bryan, Garnier & Co rating of GSK (NYSE:GSK) on 1/27/2016
GSK GSK	GBX 1,598.94 +1.0%	1/27/2016	Upgraded by	Bryan, Garnier & Co	-	Buy	GBX 1,635	N/A	View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 1/27/2016
ASML ASML	$859.44 -3.3%	1/21/2016	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy		N/A	View details for Bryan, Garnier & Co rating of ASML (NASDAQ:ASML) on 1/21/2016
TSCO Tesco	GBX 281.40 -0.5%	1/14/2016	Initiated by	Bryan, Garnier & Co	-	Neutral	GBX 166	N/A	View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 1/14/2016
PNN Pennon Group	GBX 661 +1.9%	1/8/2016	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 800	N/A	View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 1/8/2016
IHG InterContinental Hotels Group	GBX 7,816 -0.3%	1/7/2016	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 2,650	N/A	View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 1/7/2016
CPG Compass Group	GBX 2,203 +1.6%	1/5/2016	Target Raised by	Bryan, Garnier & Co	-	Neutral	GBX 1,150 -> GBX 1,200	N/A	View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 1/5/2016
SGE The Sage Group	GBX 1,140.50 -0.4%	12/18/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 540	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 12/18/2015
GLPG Galapagos	$29.05 +0.5%	12/17/2015	Target Raised by	Bryan, Garnier & Co	-	Buy	$52.00 -> $64.00	N/A	View details for Bryan, Garnier & Co rating of Galapagos (NASDAQ:GLPG) on 12/17/2015
Strange new buyer driving up gold (Ad) One Wall Street trader just made a big new gold prediction: "Pay attention to physical demand for gold... the interest seen over the last week has been unprecedented." But there's a much better move you can make to get in front of these big moves today.
DGE Diageo	GBX 2,836.50 +0.5%	12/3/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 1,870	N/A	View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 12/3/2015
TSCO Tesco	GBX 281.40 -0.5%	12/1/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral		N/A	View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 12/1/2015
PNN Pennon Group	GBX 661 +1.9%	11/27/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 800	N/A	View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 11/27/2015
SGE The Sage Group	GBX 1,140.50 -0.4%	11/27/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 540	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 11/27/2015
TSCDY Tesco	$10.65 -0.5%	11/25/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral		N/A	View details for Bryan, Garnier & Co rating of Tesco (OTCMKTS:TSCDY) on 11/25/2015
TSCO Tesco	GBX 281.40 -0.5%	11/25/2015	Initiated by	Bryan, Garnier & Co	-	Neutral		N/A	View details for Bryan, Garnier & Co rating of Tesco (LON:TSCO) on 11/25/2015
CPG Compass Group	GBX 2,203 +1.6%	11/24/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 1,150	N/A	View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 11/24/2015
TAP Molson Coors Beverage	$64.34 +0.7%	11/17/2015	Initiated by	Bryan, Garnier & Co	-	Buy	$101.00	N/A	View details for Bryan, Garnier & Co rating of Molson Coors Beverage (NYSE:TAP) on 11/17/2015
SGE The Sage Group	GBX 1,140.50 -0.4%	11/13/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 540	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 11/13/2015
AZN AstraZeneca	£108.22 -0.8%	11/12/2015	Target Raised by	Bryan, Garnier & Co	-	Buy	GBX 5,100 -> GBX 5,150	N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 11/12/2015
SNY Sanofi	$46.52 +2.5%	11/9/2015	Reiterated by	Bryan, Garnier & Co	-	Buy -> Neutral		N/A	View details for Bryan, Garnier & Co rating of Sanofi (NASDAQ:SNY) on 11/9/2015
PNN Pennon Group	GBX 661 +1.9%	10/26/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 800	N/A	View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 10/26/2015
AZN AstraZeneca	£108.22 -0.8%	10/23/2015	Reiterated by	Bryan, Garnier & Co	-	Buy	GBX 5,100	N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 10/23/2015
UBSFY Ubisoft Entertainment	$4.44 -0.9%	10/15/2015	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy		N/A	View details for Bryan, Garnier & Co rating of Ubisoft Entertainment (OTCMKTS:UBSFY) on 10/15/2015
AZN AstraZeneca	£108.22 -0.8%	10/12/2015	Reiterated by	Bryan, Garnier & Co	-	Buy	GBX 5,400	N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 10/12/2015
SGE The Sage Group	GBX 1,140.50 -0.4%	10/6/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 520	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 10/6/2015
IHG InterContinental Hotels Group	GBX 7,816 -0.3%	10/5/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral		N/A	View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 10/5/2015
DGE Diageo	GBX 2,836.50 +0.5%	10/1/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 1,870	N/A	View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 10/1/2015
DGE Diageo	GBX 2,836.50 +0.5%	9/23/2015	Target Lowered by	Bryan, Garnier & Co	-	Neutral	GBX 1,920 -> GBX 1,870	N/A	View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 9/23/2015
AZN AstraZeneca	$68.60 +0.4%	9/18/2015	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy		N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (NASDAQ:AZN) on 9/18/2015
AZN AstraZeneca	£108.22 -0.8%	9/10/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 4,830	N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 9/10/2015
GSK GSK	GBX 1,598.94 +1.0%	9/9/2015	Target Lowered by	Bryan, Garnier & Co	-	Neutral	GBX 1,480 -> GBX 1,470	N/A	View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 9/9/2015
PNN Pennon Group	GBX 661 +1.9%	8/25/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 835	N/A	View details for Bryan, Garnier & Co rating of Pennon Group (LON:PNN) on 8/25/2015
GSK GSK	GBX 1,598.94 +1.0%	8/21/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 1,480	N/A	View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 8/21/2015
AZN AstraZeneca	£108.22 -0.8%	8/21/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 4,830	N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 8/21/2015
DGE Diageo	GBX 2,836.50 +0.5%	7/29/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 1,920	N/A	View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 7/29/2015
SGE The Sage Group	GBX 1,140.50 -0.4%	7/21/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 520	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 7/21/2015
VCISY Vinci	$30.11 +0.6%	7/17/2015	Initiated by	Bryan, Garnier & Co	-	Buy		N/A	View details for Bryan, Garnier & Co rating of Vinci (OTCMKTS:VCISY) on 7/17/2015
DANOY Danone	$12.58 +0.5%	7/8/2015	Initiated by	Bryan, Garnier & Co	-	Buy		N/A	View details for Bryan, Garnier & Co rating of Danone (OTCMKTS:DANOY) on 7/8/2015
DGE Diageo	GBX 2,836.50 +0.5%	7/2/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 1,920	N/A	View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 7/2/2015
DASTY Dassault Systèmes	$40.62 -0.1%	6/30/2015	Downgraded by	Bryan, Garnier & Co	-	Neutral -> Sell		N/A	View details for Bryan, Garnier & Co rating of Dassault Systèmes (OTCMKTS:DASTY) on 6/30/2015
NVS Novartis	$94.39 +2.0%	6/22/2015	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy		N/A	View details for Bryan, Garnier & Co rating of Novartis (NYSE:NVS) on 6/22/2015
IFNNY Infineon Technologies	$32.57 -2.9%	6/11/2015	Initiated by	Bryan, Garnier & Co	-	Buy		N/A	View details for Bryan, Garnier & Co rating of Infineon Technologies (OTCMKTS:IFNNY) on 6/11/2015
DLGNF Dialog Semiconductor	$80.41	6/11/2015	Initiated by	Bryan, Garnier & Co	-	Buy		N/A	View details for Bryan, Garnier & Co rating of Dialog Semiconductor (OTCMKTS:DLGNF) on 6/11/2015
GSK GSK	GBX 1,598.94 +1.0%	6/2/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 1,580	N/A	View details for Bryan, Garnier & Co rating of GSK (LON:GSK) on 6/2/2015
IHG InterContinental Hotels Group	GBX 7,816 -0.3%	5/21/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 2,650	N/A	View details for Bryan, Garnier & Co rating of InterContinental Hotels Group (LON:IHG) on 5/21/2015
UBSFY Ubisoft Entertainment	$4.44 -0.9%	5/13/2015	Downgraded by	Bryan, Garnier & Co	-	Buy -> Neutral		N/A	View details for Bryan, Garnier & Co rating of Ubisoft Entertainment (OTCMKTS:UBSFY) on 5/13/2015
DGE Diageo	GBX 2,836.50 +0.5%	5/6/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 1,950	N/A	View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 5/6/2015
CABGY Carlsberg A/S	$25.78 +1.0%	5/5/2015	Initiated by	Bryan, Garnier & Co	-	Neutral		N/A	View details for Bryan, Garnier & Co rating of Carlsberg A/S (OTCMKTS:CABGY) on 5/5/2015
BUD Anheuser-Busch InBev SA/NV	$58.84 +1.6%	5/5/2015	Initiated by	Bryan, Garnier & Co	-	Neutral		N/A	View details for Bryan, Garnier & Co rating of Anheuser-Busch InBev SA/NV (NYSE:BUD) on 5/5/2015
AEG Aegon	$5.86 -0.5%	4/15/2015	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy		N/A	View details for Bryan, Garnier & Co rating of Aegon (NYSE:AEG) on 4/15/2015
RANJY Randstad	$25.56 +2.1%	4/14/2015	Upgraded by	Bryan, Garnier & Co	-	Sell -> Buy		N/A	View details for Bryan, Garnier & Co rating of Randstad (OTCMKTS:RANJY) on 4/14/2015
AZN AstraZeneca	£108.22 -0.8%	4/10/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 4,740	N/A	View details for Bryan, Garnier & Co rating of AstraZeneca (LON:AZN) on 4/10/2015
DGE Diageo	GBX 2,836.50 +0.5%	4/1/2015	Target Raised by	Bryan, Garnier & Co	-	Neutral	GBX 1,880 -> GBX 2,000	N/A	View details for Bryan, Garnier & Co rating of Diageo (LON:DGE) on 4/1/2015
CPG Compass Group	GBX 2,203 +1.6%	3/30/2015	Target Raised by	Bryan, Garnier & Co	-	Neutral	GBX 1,070 -> GBX 1,220	N/A	View details for Bryan, Garnier & Co rating of Compass Group (LON:CPG) on 3/30/2015
NVO Novo Nordisk A/S	$122.77 +0.0%	3/26/2015	Downgraded by	Bryan, Garnier & Co	-	Neutral		N/A	View details for Bryan, Garnier & Co rating of Novo Nordisk A/S (NYSE:NVO) on 3/26/2015
PPRUY Kering	$36.00 -0.1%	2/18/2015	Downgraded by	Bryan, Garnier & Co	-	Neutral		N/A	View details for Bryan, Garnier & Co rating of Kering (OTCMKTS:PPRUY) on 2/18/2015
LVMUY LVMH Moët Hennessy - Louis Vuitton, Société Européenne	$170.18 -0.3%	2/4/2015	Upgraded by	Bryan, Garnier & Co	-	Buy		N/A	View details for Bryan, Garnier & Co rating of LVMH Moët Hennessy - Louis Vuitton, Société Européenne (OTCMKTS:LVMUY) on 2/4/2015
SGE The Sage Group	GBX 1,140.50 -0.4%	1/29/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 450	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 1/29/2015
SGE The Sage Group	GBX 1,140.50 -0.4%	1/13/2015	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 420	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 1/13/2015
FMS Fresenius Medical Care	$19.55 +0.8%	12/18/2014	Downgraded by	Bryan, Garnier & Co	-	Neutral		N/A	View details for Bryan, Garnier & Co rating of Fresenius Medical Care (NYSE:FMS) on 12/18/2014
DEO Diageo	$140.76 0.0%	12/4/2014	Initiated by	Bryan, Garnier & Co	-	Neutral		N/A	View details for Bryan, Garnier & Co rating of Diageo (NYSE:DEO) on 12/4/2014
SGE The Sage Group	GBX 1,140.50 -0.4%	12/4/2014	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 425	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 12/4/2014
BOSSY Hugo Boss	$10.19	11/4/2014	Initiated by	Bryan, Garnier & Co	-	Buy		N/A	View details for Bryan, Garnier & Co rating of Hugo Boss (OTCMKTS:BOSSY) on 11/4/2014
VEOEY Veolia Environnement	$15.15 +1.8%	9/30/2014	Initiated by	Bryan, Garnier & Co	-	Buy		N/A	View details for Bryan, Garnier & Co rating of Veolia Environnement (OTCMKTS:VEOEY) on 9/30/2014
SGE The Sage Group	GBX 1,140.50 -0.4%	9/30/2014	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 405	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 9/30/2014
CRH CRH	$77.02 -0.2%	9/12/2014	Upgraded by	Bryan, Garnier & Co	-	Sell -> Buy		N/A	View details for Bryan, Garnier & Co rating of CRH (NYSE:CRH) on 9/12/2014
PDRDY Pernod Ricard	$47.12	8/29/2014	Upgraded by	Bryan, Garnier & Co	-	Neutral -> Buy	$23.29	N/A	View details for Bryan, Garnier & Co rating of Pernod Ricard (OTCMKTS:PDRDY) on 8/29/2014
SGE The Sage Group	GBX 1,140.50 -0.4%	7/24/2014	Reiterated by	Bryan, Garnier & Co	-	Neutral	GBX 395	N/A	View details for Bryan, Garnier & Co rating of The Sage Group (LON:SGE) on 7/24/2014
PDRDY Pernod Ricard	$47.12	5/28/2014	Initiated by	Bryan, Garnier & Co	-	Neutral		N/A	View details for Bryan, Garnier & Co rating of Pernod Ricard (OTCMKTS:PDRDY) on 5/28/2014

MarketBeat Community Rating for Bryan, Garnier & Co

Community Ranking:		2.7 out of 5 ( 2.7 of 5 stars)
Outperform Votes:		24,020 (Vote Outperform)
Underperform Votes:		20,748 (Vote Underperform)
Total Votes:		44,768

MarketBeat's community ratings are surveys of what our community members think about Bryan, Garnier & Co and other research firms. Vote "Outperform" if you believe Bryan, Garnier & Co's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe Bryan, Garnier & Co's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days.

Stock Ratings Reports and Tools

Today's Ratings:

Top Rated Stocks:

More Ratings Tools:

Ratings for Popular Stocks:

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Bryan, Garnier & Co Analyst Recommendations & Stock Picks

MarketBeat Community Rating for Bryan, Garnier & Co

Stock Ratings Reports and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info